Discovery of ARF1-targeting inhibitor demethylzeylasteral as a potential agent against breast cancer | Acta Pharmaceutica Sinica B;(6): 2619-2622, 2022. | WPRIM

Main content 1 Search 2 Footer 3

+A A -A High contrast

Discovery of ARF1-targeting inhibitor demethylzeylasteral as a potential agent against breast cancer

Jie CHANG; Ruirui YANG; Lifan CHEN; Zisheng FAN; Jingyi ZHOU; Hao GUO; Yinghui ZHANG; Yadan LIU; Guizhen ZHOU; Keke ZHANG; Kaixian CHEN; Hualiang JIANG; Mingyue ZHENG; Sulin ZHANG.

Acta Pharmaceutica Sinica B ; (6): 2619-2622, 2022.

Article in En | WPRIM | ID: wpr-929387

Responsible library: WPRO

Key words

ADP-ribosylation factor 1; Breast cancer; Demethylzeylasteral; Virtual screening

Search on Google

Full text: 1 Index: WPRIM Language: En Journal: Acta Pharmaceutica Sinica B Year: 2022 Type: Article

Search on Google

Full text: 1 Index: WPRIM Language: En Journal: Acta Pharmaceutica Sinica B Year: 2022 Type: Article